Z-2894-2026 Class II Ongoing
FDA device recall Z-2894-2026 was initiated by Aniara Diagnostica LLC on Jul 1, 2026 and is designated Class II. Reason for recall: Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls… The recall status is ongoing. Affected quantity: 4 units.
Recall details
- Product Type
- Devices
- Report Date
- Aug 12, 2026
- Initiation Date
- Jul 1, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4 units
Product description
5-PLASMA Bivalirudin AMR Verification Kit, Model Number 5D-45905
Reason for recall
Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls, calibrators, and linearity values.
Distribution pattern
US Nationwide distribution in the states of IL, NC, TN.
Code information
UDI-DI: 05070002420378, Lot Number: KE132603
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2894-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026